Physician profile
Anna Adamczyk
NPI 1407438435
$1,323.39
in general payments reported to CMS, 2019-2025
21 companies · $543 in 2025
The $543 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.50 · 2022: $162 · 2023: $194 · 2024: $388 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $188.64 | 2022-2025 | Botox |
| Endo USA, INC. | $185.88 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $179.13 | 2022-2024 | Xiaflex, Aveed, Edex |
| Progenics Pharmaceuticals, INC. | $115.25 | 2022-2025 | Pylarify |
| Sumitomo Pharma America, INC. | $92.17 | 2024-2025 | Gemtesa |
| Pfizer INC. | $81.60 | 2023-2025 | |
| 180 Medical, INC. | $56.47 | 2024-2025 | Gentlecath Glide, Gentlecath |
| Medtronic, INC. | $53.48 | 2023-2025 | Interstim |
| Teleflex LLC | $49.33 | 2025 | Barrigel |
| Procept Biorobotics Corporation | $48.62 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Vertex Pharmaceuticals Incorporated | $47.15 | 2025 | |
| Urogen Pharma, INC. | $31.20 | 2024-2025 | |
| Blue Earth Diagnostics | $29.19 | 2025 | Posluma |
| Hollister Incorporated | $25.76 | 2024 | Vapro Pocket |
| Abc Home Medical Supply, INC. | $25.76 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.82 | 2021 | |
| Verity Pharmaceuticals INC. | $21.40 | 2025 | Trelstar |
| Conmed Corporation | $20.00 | 2025 | Airseal, Visiclear, Conmed Specimen Retrieval |
| Urovant Sciences INC | $18.63 | 2022 | |
| Janssen Biotech, INC. | $17.23 | 2025 | Erleada |
| Teva Pharmaceuticals USA, INC. | $14.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Adamczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.